Cargando…
Alzheimer’s Disease, Diagnosis and the Need for Biomarkers
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder of aging that presents with memory loss, disorientation, confusion and a reduction in cognitive ability. Although a definite diagnosis of the disorder can only be made post-mortem by histopathological analysis, a number of methods...
Autores principales: | Hooper, Claudie, Lovestone, Simon, Sainz-Fuertes, Ricardo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688363/ https://www.ncbi.nlm.nih.gov/pubmed/19578515 |
Ejemplares similares
-
The GSK3 hypothesis of Alzheimer's disease
por: Hooper, Claudie, et al.
Publicado: (2008) -
Wnt3a induces exosome secretion from primary cultured rat microglia
por: Hooper, Claudie, et al.
Publicado: (2012) -
Correction to: Wnt3a induces exosome secretion from primary cultured rat microglia
por: Hooper, Claudie, et al.
Publicado: (2020) -
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
por: Hooper, Claudie, et al.
Publicado: (2007) -
Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014)